Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -39.17% is 84% below its 4-year average of -21.33%, near the low end of its 4-year range (-39.17%–-0.10%).
26.52% below its 12-month average of -30.96%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2025 (2025-06-30): -23.54%.
RETURN ON ASSETS (ROA)
-39.17%
RETURN ON ASSETS (ROA) AVG TTM
-30.96%
RETURN ON ASSETS (ROA) AVG 3Y
-31.81%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.52%
CURRENT VS 3Y AVG
-23.12%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-24.95%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
-56.99%
vs the sector median at left
Alps Group Inc
Market Cap
$66.56M
Return on Assets (ROA)
-39.17%
TTM Avg
-30.96%
3Y Avg
-31.81%
5Y Avg
N/A
Market Cap
$67.11M
Return on Assets (ROA)
-382.32%
TTM Avg
-98.02%
3Y Avg
-80.35%
5Y Avg
-65.77%
Market Cap
$65.08M
Return on Assets (ROA)
-162.91%
TTM Avg
-58.42%
3Y Avg
-64.67%
5Y Avg
-61.98%
Market Cap
$69.05M
Return on Assets (ROA)
-3.41%
TTM Avg
5.09%
3Y Avg
-8.30%
5Y Avg
-5.06%
Market Cap
$63.98M
Return on Assets (ROA)
-87.09%
TTM Avg
-130.17%
3Y Avg
-272.35%
5Y Avg
-217.34%
Market Cap
$69.43M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$70.01M
Return on Assets (ROA)
-99.89%
TTM Avg
-66.19%
3Y Avg
-52.51%
5Y Avg
-39.81%
Market Cap
$70.03M
Return on Assets (ROA)
-13.50%
TTM Avg
-6.86%
3Y Avg
-33.98%
5Y Avg
-45.40%
Market Cap
$72.02M
Return on Assets (ROA)
-33.34%
TTM Avg
-56.30%
3Y Avg
-89.26%
5Y Avg
-70.59%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $66.56M | -39.17% | -30.96% | -31.81% | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | -382.32% | -98.02% | -80.35% | -65.77% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | -162.91% | -58.42% | -64.67% | -61.98% |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | -3.41% | 5.09% | -8.30% | -5.06% |
| Cingulate Inc. (CING)vs › | $63.98M | -87.09% | -130.17% | -272.35% | -217.34% |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | 35.31% | -14.11% | -23.46% | -20.68% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | -99.89% | -66.19% | -52.51% | -39.81% |
| Heron Therapeutics, Inc. (HRTX)vs › | $70.03M | -13.50% | -6.86% | -33.98% | -45.40% |
| iBio, Inc. (IBIO)vs › | $72.02M | -33.34% | -56.30% | -89.26% | -70.59% |
| Gain Therapeutics, Inc. (GANX)vs › | $72.09M | -130.37% | -128.36% | -112.34% | -87.04% |
ROA
-39.2%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | -28.82% |
| 2026-03-31 | -28.82% |
| 2025-03-31 | -35.24% |
| 2024-03-31 | -34.38% |
| 2022-12-31 | -0.61% |
| 2021-12-31 | -0.10% |
